[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fYUlT2HB7gqUQ0oLLj7KsMm9EPaRNgqrgJpvbmCCN_sE":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":65,"rows":72},"Sahlgrenska University Hospital",[4],258,false,68,5,344056,7,210,[14,17,20,22,25,27,29,31],{"name":15,"count":16},"Irritable Bowel Syndrome",11,{"name":18,"count":19},"Surgery",10,{"name":21,"count":11},"Rectal Cancer",{"name":23,"count":24},"Quality of Life",6,{"name":26,"count":9},"Colorectal Cancer",{"name":28,"count":9},"Diabetic Foot",{"name":30,"count":9},"Hip Fractures",{"name":32,"count":33},"Rectal Neoplasms",4,[35,40,45,50,55,60],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05810792","Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer","2027-04-01","Histamine Dihydrochloride",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT04568993","The TriggerHappy Trial","2027-11-01","Volar to the MCP-joint",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT07003646","Reperfusion Treatment in Acute Pulmonary Embolism","2028-05-01","Alteplase",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT07576257","OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)","2029-12-31","potassium binder",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT07498959","Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer","2031-03-25","3 courses of chemotherapy; Blemocin, Etoposide and Platinum",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT06714604","Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR\u002FLAPC","2032-12-31","FOLFIRINOX or gemcitabine-nab-paclitaxel",[66,67,68,69,70,71],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[73,102,128,146,168,193,218,240,267,293,316,334,373,391,416,450,487,513,538,566,592,610,635,660,678,696,723,779,823,853,891,932,954,976,1000,1025,1043,1061,1087,1111,1137,1162,1187,1205,1230,1248,1273,1299,1317,1342,1366,1390,1414,1440],{"intervention":64,"totalTrials":74,"cells":75},1,{"EARLY_PHASE1":76,"PHASE1":79,"PHASE2":81,"PHASE3":83,"PHASE4":98,"NA":100},{"trials":77,"activeCount":78},[],0,{"trials":80,"activeCount":78},[],{"trials":82,"activeCount":78},[],{"trials":84,"activeCount":74,"soonestReadout":63},[85],{"nctId":61,"briefTitle":62,"status":86,"phases":87,"primaryCompletion":63,"completion":88,"start":89,"enrollment":90,"conditions":91,"interventions":97},"RECRUITING",[69],"2033-12-31","2023-10-18",432,[92,93,94,95,18,96],"Locally Advanced Pancreatic Adenocarcinoma","Borderline Resectable Pancreatic Carcinoma","Pancreas Cancer","Neoadjuvant Chemotherapy","Pancreatectomy",[64,64],{"trials":99,"activeCount":78},[],{"trials":101,"activeCount":78},[],{"intervention":39,"totalTrials":74,"cells":103},{"EARLY_PHASE1":104,"PHASE1":106,"PHASE2":108,"PHASE3":122,"PHASE4":124,"NA":126},{"trials":105,"activeCount":78},[],{"trials":107,"activeCount":78},[],{"trials":109,"activeCount":74,"soonestReadout":38},[110],{"nctId":36,"briefTitle":37,"status":111,"phases":112,"primaryCompletion":38,"completion":113,"start":114,"enrollment":115,"conditions":116,"interventions":120},"NOT_YET_RECRUITING",[68],"2028-04-01","2024-04-01",50,[117,18,118,119],"Pancreatic Cancer","Metastasis","Immunosuppression",[39,121],"Interleukin-2",{"trials":123,"activeCount":78},[],{"trials":125,"activeCount":78},[],{"trials":127,"activeCount":78},[],{"intervention":121,"totalTrials":74,"cells":129},{"EARLY_PHASE1":130,"PHASE1":132,"PHASE2":134,"PHASE3":140,"PHASE4":142,"NA":144},{"trials":131,"activeCount":78},[],{"trials":133,"activeCount":78},[],{"trials":135,"activeCount":74,"soonestReadout":38},[136],{"nctId":36,"briefTitle":37,"status":111,"phases":137,"primaryCompletion":38,"completion":113,"start":114,"enrollment":115,"conditions":138,"interventions":139},[68],[117,18,118,119],[39,121],{"trials":141,"activeCount":78},[],{"trials":143,"activeCount":78},[],{"trials":145,"activeCount":78},[],{"intervention":54,"totalTrials":74,"cells":147},{"EARLY_PHASE1":148,"PHASE1":150,"PHASE2":152,"PHASE3":162,"PHASE4":164,"NA":166},{"trials":149,"activeCount":78},[],{"trials":151,"activeCount":78},[],{"trials":153,"activeCount":74,"soonestReadout":53},[154],{"nctId":51,"briefTitle":52,"status":111,"phases":155,"primaryCompletion":53,"completion":156,"start":157,"enrollment":158,"conditions":159,"interventions":161},[68],"2030-06-30","2026-09-01",110,[160],"Heart Failure",[54],{"trials":163,"activeCount":78},[],{"trials":165,"activeCount":78},[],{"trials":167,"activeCount":78},[],{"intervention":59,"totalTrials":74,"cells":169},{"EARLY_PHASE1":170,"PHASE1":172,"PHASE2":174,"PHASE3":176,"PHASE4":178,"NA":180},{"trials":171,"activeCount":78},[],{"trials":173,"activeCount":78},[],{"trials":175,"activeCount":78},[],{"trials":177,"activeCount":78},[],{"trials":179,"activeCount":78},[],{"trials":181,"activeCount":74,"soonestReadout":58},[182],{"nctId":56,"briefTitle":57,"status":86,"phases":183,"primaryCompletion":58,"completion":184,"start":185,"enrollment":186,"conditions":187,"interventions":192},[71],"2032-03-25","2026-03-19",160,[188,189,23,190,191],"Testicular Cancer","Seminoma","De-escalation","RPLND",[59],{"intervention":44,"totalTrials":74,"cells":194},{"EARLY_PHASE1":195,"PHASE1":197,"PHASE2":199,"PHASE3":201,"PHASE4":203,"NA":205},{"trials":196,"activeCount":78},[],{"trials":198,"activeCount":78},[],{"trials":200,"activeCount":78},[],{"trials":202,"activeCount":78},[],{"trials":204,"activeCount":78},[],{"trials":206,"activeCount":74,"soonestReadout":43},[207],{"nctId":41,"briefTitle":42,"status":208,"phases":209,"primaryCompletion":43,"completion":210,"start":211,"enrollment":212,"conditions":213,"interventions":217},"ACTIVE_NOT_RECRUITING",[71],"2028-07-01","2020-10-01",100,[214,215,216],"Trigger Finger","Trigger Thumb","Minimally Invasive Surgery",[44],{"intervention":49,"totalTrials":74,"cells":219},{"EARLY_PHASE1":220,"PHASE1":222,"PHASE2":224,"PHASE3":226,"PHASE4":228,"NA":230},{"trials":221,"activeCount":78},[],{"trials":223,"activeCount":78},[],{"trials":225,"activeCount":78},[],{"trials":227,"activeCount":78},[],{"trials":229,"activeCount":78},[],{"trials":231,"activeCount":74,"soonestReadout":48},[232],{"nctId":46,"briefTitle":47,"status":86,"phases":233,"primaryCompletion":48,"completion":234,"start":235,"enrollment":236,"conditions":237,"interventions":239},[],"2029-05-01","2025-04-01",220,[238],"Pulmonary Embolism",[49],{"intervention":241,"totalTrials":74,"cells":242},"reteplase 10+10 U",{"EARLY_PHASE1":243,"PHASE1":245,"PHASE2":247,"PHASE3":249,"PHASE4":251,"NA":265},{"trials":244,"activeCount":78},[],{"trials":246,"activeCount":78},[],{"trials":248,"activeCount":78},[],{"trials":250,"activeCount":78},[],{"trials":252,"activeCount":78},[253],{"nctId":254,"briefTitle":255,"status":256,"phases":257,"primaryCompletion":258,"completion":259,"start":260,"enrollment":261,"conditions":262,"interventions":264},"NCT00806403","Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction","COMPLETED",[70],"2003-06","2004-06","2001-11",205,[263],"Acute Myocardial Infarction",[241],{"trials":266,"activeCount":78},[],{"intervention":268,"totalTrials":74,"cells":269},"Norepinephrine 1 MG\u002FML",{"EARLY_PHASE1":270,"PHASE1":272,"PHASE2":274,"PHASE3":276,"PHASE4":278,"NA":291},{"trials":271,"activeCount":78},[],{"trials":273,"activeCount":78},[],{"trials":275,"activeCount":78},[],{"trials":277,"activeCount":78},[],{"trials":279,"activeCount":78},[280],{"nctId":281,"briefTitle":282,"status":256,"phases":283,"primaryCompletion":284,"completion":284,"start":285,"enrollment":286,"conditions":287,"interventions":290},"NCT05564741","Acute Hip Fracture and Spinal Anaesthesia Injection Time",[70],"2024-12-31","2022-10-20",84,[288,30,289],"Hypotension","Anesthesia",[268],{"trials":292,"activeCount":78},[],{"intervention":294,"totalTrials":74,"cells":295},"Metoprolol",{"EARLY_PHASE1":296,"PHASE1":298,"PHASE2":300,"PHASE3":302,"PHASE4":304,"NA":314},{"trials":297,"activeCount":78},[],{"trials":299,"activeCount":78},[],{"trials":301,"activeCount":78},[],{"trials":303,"activeCount":78},[],{"trials":305,"activeCount":78},[306],{"nctId":307,"briefTitle":308,"status":256,"phases":309,"conditions":310,"interventions":312},"NCT00718406","Pain Relief of Metoprolol Versus Metoprolol Plus Morphine in Acute Chest Pain",[70],[311],"Acute Coronary Syndromes",[294,313],"metoprolol plus morphine",{"trials":315,"activeCount":78},[],{"intervention":313,"totalTrials":74,"cells":317},{"EARLY_PHASE1":318,"PHASE1":320,"PHASE2":322,"PHASE3":324,"PHASE4":326,"NA":332},{"trials":319,"activeCount":78},[],{"trials":321,"activeCount":78},[],{"trials":323,"activeCount":78},[],{"trials":325,"activeCount":78},[],{"trials":327,"activeCount":78},[328],{"nctId":307,"briefTitle":308,"status":256,"phases":329,"conditions":330,"interventions":331},[70],[311],[294,313],{"trials":333,"activeCount":78},[],{"intervention":335,"totalTrials":336,"cells":337},"Disulfiram",2,{"EARLY_PHASE1":338,"PHASE1":352,"PHASE2":354,"PHASE3":356,"PHASE4":369,"NA":371},{"trials":339,"activeCount":78},[340],{"nctId":341,"briefTitle":342,"status":343,"phases":344,"primaryCompletion":345,"completion":345,"start":346,"enrollment":347,"conditions":348,"interventions":350},"NCT03151772","Bioavailability of Disulfiram and Metformin in Glioblastomas","TERMINATED",[66],"2020-09-24","2018-01-29",3,[349],"Glioblastoma",[335,351],"Metformin",{"trials":353,"activeCount":78},[],{"trials":355,"activeCount":78},[],{"trials":357,"activeCount":78},[358],{"nctId":359,"briefTitle":360,"status":256,"phases":361,"primaryCompletion":362,"completion":362,"start":363,"enrollment":364,"conditions":365,"interventions":367},"NCT02678975","Disulfiram in Recurrent Glioblastoma",[68,69],"2021-01-15","2017-01",88,[366,349],"Glioma",[335,368],"Alkylating Agents",{"trials":370,"activeCount":78},[],{"trials":372,"activeCount":78},[],{"intervention":368,"totalTrials":74,"cells":374},{"EARLY_PHASE1":375,"PHASE1":377,"PHASE2":379,"PHASE3":381,"PHASE4":387,"NA":389},{"trials":376,"activeCount":78},[],{"trials":378,"activeCount":78},[],{"trials":380,"activeCount":78},[],{"trials":382,"activeCount":78},[383],{"nctId":359,"briefTitle":360,"status":256,"phases":384,"primaryCompletion":362,"completion":362,"start":363,"enrollment":364,"conditions":385,"interventions":386},[68,69],[366,349],[335,368],{"trials":388,"activeCount":78},[],{"trials":390,"activeCount":78},[],{"intervention":392,"totalTrials":74,"cells":393},"ANP",{"EARLY_PHASE1":394,"PHASE1":396,"PHASE2":398,"PHASE3":400,"PHASE4":412,"NA":414},{"trials":395,"activeCount":78},[],{"trials":397,"activeCount":78},[],{"trials":399,"activeCount":78},[],{"trials":401,"activeCount":78},[402],{"nctId":403,"briefTitle":404,"status":256,"phases":405,"primaryCompletion":406,"completion":406,"start":407,"enrollment":408,"conditions":409,"interventions":411},"NCT02665377","Prevention of Akute Kidney Injury, Hearttransplant, ANP",[69],"2022-01-08","2016-09-25",86,[410],"Acute Kidney Injury",[392],{"trials":413,"activeCount":78},[],{"trials":415,"activeCount":78},[],{"intervention":417,"totalTrials":74,"cells":418},"Capsules containing either dietary fiber or placebo",{"EARLY_PHASE1":419,"PHASE1":421,"PHASE2":423,"PHASE3":425,"PHASE4":446,"NA":448},{"trials":420,"activeCount":78},[],{"trials":422,"activeCount":78},[],{"trials":424,"activeCount":78},[],{"trials":426,"activeCount":78},[427],{"nctId":428,"briefTitle":429,"status":256,"phases":430,"primaryCompletion":431,"completion":431,"start":432,"enrollment":433,"conditions":434,"interventions":445},"NCT04534075","Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial",[69],"2024-09-14","2020-09-02",354,[435,436,437,438,439,440,441,442,443,444],"Malignant Neoplasm","Malignant Neoplasm of Rectum","Malignant Neoplasm of Anus","Malignant Neoplasm of Urinary Bladder","Malignant Neoplasm of Cervix","Malignant Neoplasm of Ovary","Malignant Neoplasm of Prostate","Malignant Neoplasm of Large Intestine","Malignant Neoplasm of Colon","Gynecologic Cancer",[417],{"trials":447,"activeCount":78},[],{"trials":449,"activeCount":78},[],{"intervention":451,"totalTrials":336,"cells":452},"Obeticholic acid",{"EARLY_PHASE1":453,"PHASE1":455,"PHASE2":470,"PHASE3":481,"PHASE4":483,"NA":485},{"trials":454,"activeCount":78},[],{"trials":456,"activeCount":78},[457],{"nctId":458,"briefTitle":459,"status":460,"phases":461,"primaryCompletion":462,"completion":463,"start":464,"enrollment":465,"conditions":466,"interventions":468},"NCT02532335","Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers","UNKNOWN",[67],"2020-12","2021-06","2015-08",40,[467],"Obesity",[451,469],"Obeticholic acid placebo",{"trials":471,"activeCount":78},[472],{"nctId":473,"briefTitle":474,"status":256,"phases":475,"primaryCompletion":476,"completion":476,"start":477,"enrollment":465,"conditions":478,"interventions":480},"NCT01625026","Obeticholic Acid in Bariatric and Gallstone Disease",[68],"2016-04","2013-09",[467,479],"Gallstones",[451],{"trials":482,"activeCount":78},[],{"trials":484,"activeCount":78},[],{"trials":486,"activeCount":78},[],{"intervention":488,"totalTrials":74,"cells":489},"varenicline",{"EARLY_PHASE1":490,"PHASE1":492,"PHASE2":494,"PHASE3":507,"PHASE4":509,"NA":511},{"trials":491,"activeCount":78},[],{"trials":493,"activeCount":78},[],{"trials":495,"activeCount":78},[496],{"nctId":497,"briefTitle":498,"status":256,"phases":499,"primaryCompletion":500,"completion":501,"start":502,"enrollment":503,"conditions":504,"interventions":506},"NCT00846859","Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?",[68],"2010-08","2011-01","2009-03",162,[505],"Alcohol Dependence",[488],{"trials":508,"activeCount":78},[],{"trials":510,"activeCount":78},[],{"trials":512,"activeCount":78},[],{"intervention":514,"totalTrials":74,"cells":515},"A4250",{"EARLY_PHASE1":516,"PHASE1":518,"PHASE2":520,"PHASE3":532,"PHASE4":534,"NA":536},{"trials":517,"activeCount":78},[],{"trials":519,"activeCount":78},[],{"trials":521,"activeCount":78},[522],{"nctId":523,"briefTitle":524,"status":343,"phases":525,"primaryCompletion":526,"completion":526,"start":527,"enrollment":528,"conditions":529,"interventions":531},"NCT02360852","IBAT Inhibitor A4250 for Cholestatic Pruritus",[68],"2016-10","2015-01",9,[530],"Biliary Cirrhosis, Primary",[514],{"trials":533,"activeCount":78},[],{"trials":535,"activeCount":78},[],{"trials":537,"activeCount":78},[],{"intervention":539,"totalTrials":74,"cells":540},"Fibrinogen",{"EARLY_PHASE1":541,"PHASE1":543,"PHASE2":545,"PHASE3":560,"PHASE4":562,"NA":564},{"trials":542,"activeCount":78},[],{"trials":544,"activeCount":78},[],{"trials":546,"activeCount":78},[547],{"nctId":548,"briefTitle":549,"status":256,"phases":550,"primaryCompletion":551,"completion":552,"start":553,"enrollment":554,"conditions":555,"interventions":559},"NCT00968045","Fibrinogen and Bleeding After Cardiac Surgery",[68],"2012-02","2015-05","2009-04",52,[556,557,558],"Complications","Bleeding","Coronary Artery Disease",[539],{"trials":561,"activeCount":78},[],{"trials":563,"activeCount":78},[],{"trials":565,"activeCount":78},[],{"intervention":567,"totalTrials":74,"cells":568},"Platelet transfusion",{"EARLY_PHASE1":569,"PHASE1":571,"PHASE2":573,"PHASE3":586,"PHASE4":588,"NA":590},{"trials":570,"activeCount":78},[],{"trials":572,"activeCount":78},[],{"trials":574,"activeCount":78},[575],{"nctId":576,"briefTitle":577,"status":460,"phases":578,"primaryCompletion":579,"completion":580,"start":581,"enrollment":465,"conditions":582,"interventions":584},"NCT04807621","Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery",[68],"2022-01","2022-08","2018-03-14",[583],"Congenital Heart Disease",[567,585],"Fibrinogen concentrate",{"trials":587,"activeCount":78},[],{"trials":589,"activeCount":78},[],{"trials":591,"activeCount":78},[],{"intervention":585,"totalTrials":74,"cells":593},{"EARLY_PHASE1":594,"PHASE1":596,"PHASE2":598,"PHASE3":604,"PHASE4":606,"NA":608},{"trials":595,"activeCount":78},[],{"trials":597,"activeCount":78},[],{"trials":599,"activeCount":78},[600],{"nctId":576,"briefTitle":577,"status":460,"phases":601,"primaryCompletion":579,"completion":580,"start":581,"enrollment":465,"conditions":602,"interventions":603},[68],[583],[567,585],{"trials":605,"activeCount":78},[],{"trials":607,"activeCount":78},[],{"trials":609,"activeCount":78},[],{"intervention":611,"totalTrials":74,"cells":612},"mirtazapine",{"EARLY_PHASE1":613,"PHASE1":615,"PHASE2":617,"PHASE3":629,"PHASE4":631,"NA":633},{"trials":614,"activeCount":78},[],{"trials":616,"activeCount":78},[],{"trials":618,"activeCount":78},[619],{"nctId":620,"briefTitle":621,"status":256,"phases":622,"primaryCompletion":623,"completion":624,"start":625,"enrollment":626,"conditions":627,"interventions":628},"NCT00874003","The Effects of Mirtazapine Versus Placebo on Alcohol Consumption in Male Alcohol High Consumers",[68],"2006-07","2009-02","2004-04",59,[505],[611],{"trials":630,"activeCount":78},[],{"trials":632,"activeCount":78},[],{"trials":634,"activeCount":78},[],{"intervention":636,"totalTrials":74,"cells":637},"Midazolam",{"EARLY_PHASE1":638,"PHASE1":640,"PHASE2":652,"PHASE3":654,"PHASE4":656,"NA":658},{"trials":639,"activeCount":78},[],{"trials":641,"activeCount":78},[642],{"nctId":643,"briefTitle":644,"status":256,"phases":645,"primaryCompletion":646,"start":647,"enrollment":648,"conditions":649,"interventions":651},"NCT00792181","To Relieve Pain and Anxiety - an Intervention Study in Ambulance Services",[67],"2008-11","2008-06",2800,[263,650],"Pain",[636],{"trials":653,"activeCount":78},[],{"trials":655,"activeCount":78},[],{"trials":657,"activeCount":78},[],{"trials":659,"activeCount":78},[],{"intervention":469,"totalTrials":74,"cells":661},{"EARLY_PHASE1":662,"PHASE1":664,"PHASE2":670,"PHASE3":672,"PHASE4":674,"NA":676},{"trials":663,"activeCount":78},[],{"trials":665,"activeCount":78},[666],{"nctId":458,"briefTitle":459,"status":460,"phases":667,"primaryCompletion":462,"completion":463,"start":464,"enrollment":465,"conditions":668,"interventions":669},[67],[467],[451,469],{"trials":671,"activeCount":78},[],{"trials":673,"activeCount":78},[],{"trials":675,"activeCount":78},[],{"trials":677,"activeCount":78},[],{"intervention":351,"totalTrials":74,"cells":679},{"EARLY_PHASE1":680,"PHASE1":686,"PHASE2":688,"PHASE3":690,"PHASE4":692,"NA":694},{"trials":681,"activeCount":78},[682],{"nctId":341,"briefTitle":342,"status":343,"phases":683,"primaryCompletion":345,"completion":345,"start":346,"enrollment":347,"conditions":684,"interventions":685},[66],[349],[335,351],{"trials":687,"activeCount":78},[],{"trials":689,"activeCount":78},[],{"trials":691,"activeCount":78},[],{"trials":693,"activeCount":78},[],{"trials":695,"activeCount":78},[],{"intervention":697,"totalTrials":74,"cells":698},"vasopressin + nitro",{"EARLY_PHASE1":699,"PHASE1":713,"PHASE2":715,"PHASE3":717,"PHASE4":719,"NA":721},{"trials":700,"activeCount":78},[701],{"nctId":702,"briefTitle":703,"status":256,"phases":704,"primaryCompletion":705,"completion":705,"start":706,"enrollment":707,"conditions":708,"interventions":712},"NCT02993640","Optimization of Hepatic Hemodynamics During Liver Surgery",[66],"2017-03-20","2016-09",13,[709,710,711],"Portal Blood Pressure","Liver Surgery","Hepatic Hemodynamics",[697],{"trials":714,"activeCount":78},[],{"trials":716,"activeCount":78},[],{"trials":718,"activeCount":78},[],{"trials":720,"activeCount":78},[],{"trials":722,"activeCount":78},[],{"intervention":724,"totalTrials":33,"cells":725},"Norepinephrine",{"EARLY_PHASE1":726,"PHASE1":728,"PHASE2":730,"PHASE3":732,"PHASE4":734,"NA":749},{"trials":727,"activeCount":78},[],{"trials":729,"activeCount":78},[],{"trials":731,"activeCount":78},[],{"trials":733,"activeCount":78},[],{"trials":735,"activeCount":78},[736],{"nctId":737,"briefTitle":738,"status":460,"phases":739,"primaryCompletion":740,"completion":740,"start":741,"enrollment":742,"conditions":743,"interventions":746},"NCT02640846","Effects of Levosimendan, Milrinone and Norepinephrine on Left and Right Ventricular Function in Septic Shock",[70],"2019-01","2015-12",30,[744,745],"Septic Shock","Cardiomyopathy",[724,747,748],"Milrinone","Levosimendan",{"trials":750,"activeCount":78},[751,760,770],{"nctId":752,"briefTitle":753,"status":256,"phases":754,"primaryCompletion":755,"completion":755,"start":526,"enrollment":756,"conditions":757,"interventions":759},"NCT02832596","Changes in Measured Plasma Volume, Glycocalyx and Atrial Natriuretic Peptide During Anaesthesia",[71],"2019-08-20",24,[758,289],"Blood Pressure",[724],{"nctId":761,"briefTitle":762,"status":256,"phases":763,"primaryCompletion":764,"completion":764,"start":527,"enrollment":765,"conditions":766,"interventions":768},"NCT02455115","Renal Perfusion, Filtration and Oxygenation After Liver Transplantation -Effects of av Postoperative Blood Pressure",[71],"2016-02",12,[410,767],"Liver Failure",[724,769],"Chromium ethylenediaminetetraacetic acid",{"nctId":771,"briefTitle":772,"status":460,"phases":773,"primaryCompletion":774,"completion":552,"start":775,"enrollment":756,"conditions":776,"interventions":778},"NCT02412189","Pressure-dependent Changes in Hematocrit and Plasma Volume During Anesthesia",[71],"2015-04","2014-02",[758,777,289],"Hematocrit Change",[724],{"intervention":747,"totalTrials":347,"cells":780},{"EARLY_PHASE1":781,"PHASE1":783,"PHASE2":785,"PHASE3":787,"PHASE4":789,"NA":795},{"trials":782,"activeCount":78},[],{"trials":784,"activeCount":78},[],{"trials":786,"activeCount":78},[],{"trials":788,"activeCount":78},[],{"trials":790,"activeCount":78},[791],{"nctId":737,"briefTitle":738,"status":460,"phases":792,"primaryCompletion":740,"completion":740,"start":741,"enrollment":742,"conditions":793,"interventions":794},[70],[744,745],[724,747,748],{"trials":796,"activeCount":78},[797,810],{"nctId":798,"briefTitle":799,"status":256,"phases":800,"primaryCompletion":801,"completion":802,"start":803,"enrollment":742,"conditions":804,"interventions":809},"NCT02408003","Changes in Cardiac Deformation Following Physiologic Alterations and Inotropic Support.",[71],"2016-05","2017-05","2014-03",[805,806,807,808],"Heart Failure, Diastolic","Aortic Valve Stenosis","Monitoring, Physiologic","Physiology",[748,747],{"nctId":811,"briefTitle":812,"status":256,"phases":813,"primaryCompletion":814,"completion":815,"start":816,"enrollment":817,"conditions":818,"interventions":822},"NCT02549066","Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation",[71],"2017-06","2017-08","2016-01",18,[819,820,821],"Complication of Extracorporeal Circulation","Kidney Circulation Disorder","Renal Function Disorder",[747],{"intervention":748,"totalTrials":347,"cells":824},{"EARLY_PHASE1":825,"PHASE1":827,"PHASE2":829,"PHASE3":831,"PHASE4":833,"NA":847},{"trials":826,"activeCount":78},[],{"trials":828,"activeCount":78},[],{"trials":830,"activeCount":78},[],{"trials":832,"activeCount":78},[],{"trials":834,"activeCount":78},[835,839],{"nctId":737,"briefTitle":738,"status":460,"phases":836,"primaryCompletion":740,"completion":740,"start":741,"enrollment":742,"conditions":837,"interventions":838},[70],[744,745],[724,747,748],{"nctId":840,"briefTitle":841,"status":256,"phases":842,"primaryCompletion":462,"completion":462,"start":843,"enrollment":742,"conditions":844,"interventions":846},"NCT02531724","Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery",[70],"2015-09",[410,845],"Renal Insufficiency, Acute",[748],{"trials":848,"activeCount":78},[849],{"nctId":798,"briefTitle":799,"status":256,"phases":850,"primaryCompletion":801,"completion":802,"start":803,"enrollment":742,"conditions":851,"interventions":852},[71],[805,806,807,808],[748,747],{"intervention":854,"totalTrials":336,"cells":855},"Probiotic",{"EARLY_PHASE1":856,"PHASE1":858,"PHASE2":860,"PHASE3":862,"PHASE4":864,"NA":866},{"trials":857,"activeCount":78},[],{"trials":859,"activeCount":78},[],{"trials":861,"activeCount":78},[],{"trials":863,"activeCount":78},[],{"trials":865,"activeCount":78},[],{"trials":867,"activeCount":78},[868,879],{"nctId":869,"briefTitle":870,"status":256,"phases":871,"primaryCompletion":872,"completion":872,"start":873,"enrollment":742,"conditions":874,"interventions":876},"NCT02693028","Lactobacillus Reuteri Feasibility Study on Probiotic Treatment and Perinatal Microbiome",[71],"2018-01","2015-11",[875],"Pregnancy",[877,854,878],"Probiotic lozenges","Probiotic chewing gum",{"nctId":880,"briefTitle":881,"status":256,"phases":882,"primaryCompletion":883,"completion":883,"start":884,"enrollment":885,"conditions":886,"interventions":889},"NCT02693041","Pregnancy Complications - A Probiotic Interventional Study",[71],"2021-09-27","2012-06",105,[887,888],"Preeclampsia","Preterm Birth",[890],"probiotic",{"intervention":892,"totalTrials":336,"cells":893},"NSAID",{"EARLY_PHASE1":894,"PHASE1":896,"PHASE2":898,"PHASE3":900,"PHASE4":902,"NA":904},{"trials":895,"activeCount":78},[],{"trials":897,"activeCount":78},[],{"trials":899,"activeCount":78},[],{"trials":901,"activeCount":78},[],{"trials":903,"activeCount":78},[],{"trials":905,"activeCount":78},[906,919],{"nctId":907,"briefTitle":908,"status":909,"phases":910,"primaryCompletion":911,"completion":911,"start":912,"enrollment":78,"conditions":913,"interventions":916},"NCT02094807","Pain as Indication for Operative Treatment of Traumatic Rib Fractures","WITHDRAWN",[71],"2020-05","2014-04",[914,915,18,650],"Trauma","Rib Fractures",[892,917,918],"opioids","paracetamol",{"nctId":920,"briefTitle":921,"status":256,"phases":922,"primaryCompletion":814,"completion":923,"start":924,"enrollment":925,"conditions":926,"interventions":928},"NCT02132416","Operative Treatment of Unstable Thoracic Cage Injuries and Chest Wall Deformity in Trauma",[71],"2018-12","2014-05",92,[914,927,915,18],"Flail Chest",[892,929,930,931],"Opioids","Thoracic Epidural anaesthesia","Paracetamol",{"intervention":917,"totalTrials":336,"cells":933},{"EARLY_PHASE1":934,"PHASE1":936,"PHASE2":938,"PHASE3":940,"PHASE4":942,"NA":944},{"trials":935,"activeCount":78},[],{"trials":937,"activeCount":78},[],{"trials":939,"activeCount":78},[],{"trials":941,"activeCount":78},[],{"trials":943,"activeCount":78},[],{"trials":945,"activeCount":78},[946,950],{"nctId":907,"briefTitle":908,"status":909,"phases":947,"primaryCompletion":911,"completion":911,"start":912,"enrollment":78,"conditions":948,"interventions":949},[71],[914,915,18,650],[892,917,918],{"nctId":920,"briefTitle":921,"status":256,"phases":951,"primaryCompletion":814,"completion":923,"start":924,"enrollment":925,"conditions":952,"interventions":953},[71],[914,927,915,18],[892,929,930,931],{"intervention":918,"totalTrials":336,"cells":955},{"EARLY_PHASE1":956,"PHASE1":958,"PHASE2":960,"PHASE3":962,"PHASE4":964,"NA":966},{"trials":957,"activeCount":78},[],{"trials":959,"activeCount":78},[],{"trials":961,"activeCount":78},[],{"trials":963,"activeCount":78},[],{"trials":965,"activeCount":78},[],{"trials":967,"activeCount":78},[968,972],{"nctId":907,"briefTitle":908,"status":909,"phases":969,"primaryCompletion":911,"completion":911,"start":912,"enrollment":78,"conditions":970,"interventions":971},[71],[914,915,18,650],[892,917,918],{"nctId":920,"briefTitle":921,"status":256,"phases":973,"primaryCompletion":814,"completion":923,"start":924,"enrollment":925,"conditions":974,"interventions":975},[71],[914,927,915,18],[892,929,930,931],{"intervention":977,"totalTrials":74,"cells":978},"Pantoprazole",{"EARLY_PHASE1":979,"PHASE1":981,"PHASE2":983,"PHASE3":985,"PHASE4":987,"NA":989},{"trials":980,"activeCount":78},[],{"trials":982,"activeCount":78},[],{"trials":984,"activeCount":78},[],{"trials":986,"activeCount":78},[],{"trials":988,"activeCount":78},[],{"trials":990,"activeCount":78},[991],{"nctId":992,"briefTitle":993,"status":256,"phases":994,"primaryCompletion":995,"completion":995,"start":996,"enrollment":115,"conditions":997,"interventions":999},"NCT00915239","Symptom Evaluation After Cessation of a Proton Pump Inhibitor in Healthy Volunteers",[71],"2006-10","2006-01",[998],"Healthy",[977],{"intervention":1001,"totalTrials":74,"cells":1002},"felodipin",{"EARLY_PHASE1":1003,"PHASE1":1005,"PHASE2":1007,"PHASE3":1009,"PHASE4":1011,"NA":1013},{"trials":1004,"activeCount":78},[],{"trials":1006,"activeCount":78},[],{"trials":1008,"activeCount":78},[],{"trials":1010,"activeCount":78},[],{"trials":1012,"activeCount":78},[],{"trials":1014,"activeCount":78},[1015],{"nctId":1016,"briefTitle":1017,"status":256,"phases":1018,"primaryCompletion":1019,"completion":1019,"start":1020,"enrollment":1021,"conditions":1022,"interventions":1024},"NCT01390701","Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation",[71],"2009-09","2008-01",41,[1023],"Hypertension",[1001],{"intervention":877,"totalTrials":74,"cells":1026},{"EARLY_PHASE1":1027,"PHASE1":1029,"PHASE2":1031,"PHASE3":1033,"PHASE4":1035,"NA":1037},{"trials":1028,"activeCount":78},[],{"trials":1030,"activeCount":78},[],{"trials":1032,"activeCount":78},[],{"trials":1034,"activeCount":78},[],{"trials":1036,"activeCount":78},[],{"trials":1038,"activeCount":78},[1039],{"nctId":869,"briefTitle":870,"status":256,"phases":1040,"primaryCompletion":872,"completion":872,"start":873,"enrollment":742,"conditions":1041,"interventions":1042},[71],[875],[877,854,878],{"intervention":878,"totalTrials":74,"cells":1044},{"EARLY_PHASE1":1045,"PHASE1":1047,"PHASE2":1049,"PHASE3":1051,"PHASE4":1053,"NA":1055},{"trials":1046,"activeCount":78},[],{"trials":1048,"activeCount":78},[],{"trials":1050,"activeCount":78},[],{"trials":1052,"activeCount":78},[],{"trials":1054,"activeCount":78},[],{"trials":1056,"activeCount":78},[1057],{"nctId":869,"briefTitle":870,"status":256,"phases":1058,"primaryCompletion":872,"completion":872,"start":873,"enrollment":742,"conditions":1059,"interventions":1060},[71],[875],[877,854,878],{"intervention":1062,"totalTrials":74,"cells":1063},"Oxycodone",{"EARLY_PHASE1":1064,"PHASE1":1066,"PHASE2":1068,"PHASE3":1070,"PHASE4":1072,"NA":1074},{"trials":1065,"activeCount":78},[],{"trials":1067,"activeCount":78},[],{"trials":1069,"activeCount":78},[],{"trials":1071,"activeCount":78},[],{"trials":1073,"activeCount":78},[],{"trials":1075,"activeCount":78},[1076],{"nctId":1077,"briefTitle":1078,"status":256,"phases":1079,"primaryCompletion":1080,"completion":1081,"start":1082,"enrollment":1083,"conditions":1084,"interventions":1086},"NCT03386318","Oxycodone Concentration in the Blood After Oral Premedication",[],"2020-05-10","2021-05-01","2019-01-01",20,[1085],"Oxycontin",[1062],{"intervention":1088,"totalTrials":74,"cells":1089},"Methylprednisolone",{"EARLY_PHASE1":1090,"PHASE1":1092,"PHASE2":1094,"PHASE3":1096,"PHASE4":1098,"NA":1100},{"trials":1091,"activeCount":78},[],{"trials":1093,"activeCount":78},[],{"trials":1095,"activeCount":78},[],{"trials":1097,"activeCount":78},[],{"trials":1099,"activeCount":78},[],{"trials":1101,"activeCount":78},[1102],{"nctId":1103,"briefTitle":1104,"status":256,"phases":1105,"primaryCompletion":1106,"completion":1106,"start":1107,"enrollment":742,"conditions":1108,"interventions":1110},"NCT01755338","Effect of Steroids on Cerebral Inflammation and Neuronal Damage After Surgical Aortic Valve Replacement",[71],"2017-02","2012-12",[1109],"Aortic Stenosis",[1088],{"intervention":1112,"totalTrials":74,"cells":1113},"Bupivacain",{"EARLY_PHASE1":1114,"PHASE1":1116,"PHASE2":1118,"PHASE3":1120,"PHASE4":1122,"NA":1124},{"trials":1115,"activeCount":78},[],{"trials":1117,"activeCount":78},[],{"trials":1119,"activeCount":78},[],{"trials":1121,"activeCount":78},[],{"trials":1123,"activeCount":78},[],{"trials":1125,"activeCount":78},[1126],{"nctId":1127,"briefTitle":1128,"status":256,"phases":1129,"primaryCompletion":1130,"completion":1131,"start":362,"enrollment":1132,"conditions":1133,"interventions":1136},"NCT05101291","Fractional Spinal Anesthesia and Systemic Hemodynamics in Frail Elderly Hip Fracture Patients.",[71],"2021-02-15","2021-02-16",15,[30,289,1134,1135],"Hypotension Drug-Induced","Cardiac Output, Low",[1112],{"intervention":1138,"totalTrials":74,"cells":1139},"Treatment as usual - medicine",{"EARLY_PHASE1":1140,"PHASE1":1142,"PHASE2":1144,"PHASE3":1146,"PHASE4":1148,"NA":1150},{"trials":1141,"activeCount":78},[],{"trials":1143,"activeCount":78},[],{"trials":1145,"activeCount":78},[],{"trials":1147,"activeCount":78},[],{"trials":1149,"activeCount":78},[],{"trials":1151,"activeCount":78},[1152],{"nctId":1153,"briefTitle":1154,"status":343,"phases":1155,"primaryCompletion":1156,"completion":1156,"start":1157,"enrollment":1158,"conditions":1159,"interventions":1161},"NCT02503124","Effect of a Single Nights' Wake Followed by Bright Light Therapy for Severe Depression",[71],"2020-03-15","2015-07",32,[1160],"Depression",[1138],{"intervention":1163,"totalTrials":74,"cells":1164},"crystalloid",{"EARLY_PHASE1":1165,"PHASE1":1167,"PHASE2":1169,"PHASE3":1171,"PHASE4":1173,"NA":1175},{"trials":1166,"activeCount":78},[],{"trials":1168,"activeCount":78},[],{"trials":1170,"activeCount":78},[],{"trials":1172,"activeCount":78},[],{"trials":1174,"activeCount":78},[],{"trials":1176,"activeCount":78},[1177],{"nctId":1178,"briefTitle":1179,"status":256,"phases":1180,"primaryCompletion":1181,"completion":1181,"start":1182,"enrollment":742,"conditions":1183,"interventions":1185},"NCT01729364","Fluid Investigation Colloid vs Crystalloid Reg. Renal Hemodynamics and Function",[71],"2014-12","2008-04",[1184],"Renal Impairment",[1163,1186],"colloid",{"intervention":1186,"totalTrials":74,"cells":1188},{"EARLY_PHASE1":1189,"PHASE1":1191,"PHASE2":1193,"PHASE3":1195,"PHASE4":1197,"NA":1199},{"trials":1190,"activeCount":78},[],{"trials":1192,"activeCount":78},[],{"trials":1194,"activeCount":78},[],{"trials":1196,"activeCount":78},[],{"trials":1198,"activeCount":78},[],{"trials":1200,"activeCount":78},[1201],{"nctId":1178,"briefTitle":1179,"status":256,"phases":1202,"primaryCompletion":1181,"completion":1181,"start":1182,"enrollment":742,"conditions":1203,"interventions":1204},[71],[1184],[1163,1186],{"intervention":1206,"totalTrials":74,"cells":1207},"MAP intervention using Noradrenalin",{"EARLY_PHASE1":1208,"PHASE1":1210,"PHASE2":1212,"PHASE3":1214,"PHASE4":1216,"NA":1218},{"trials":1209,"activeCount":78},[],{"trials":1211,"activeCount":78},[],{"trials":1213,"activeCount":78},[],{"trials":1215,"activeCount":78},[],{"trials":1217,"activeCount":78},[],{"trials":1219,"activeCount":78},[1220],{"nctId":1221,"briefTitle":1222,"status":460,"phases":1223,"primaryCompletion":1224,"completion":1224,"start":1225,"enrollment":1083,"conditions":1226,"interventions":1229},"NCT03087669","Central and Cerebral Circulation in Early Stages After LVAD Implantation",[71],"2020-03-01","2017-02-16",[1227,1228],"Heart Failure, Left-Sided","Heart Failure, Right-Sided",[1206],{"intervention":930,"totalTrials":74,"cells":1231},{"EARLY_PHASE1":1232,"PHASE1":1234,"PHASE2":1236,"PHASE3":1238,"PHASE4":1240,"NA":1242},{"trials":1233,"activeCount":78},[],{"trials":1235,"activeCount":78},[],{"trials":1237,"activeCount":78},[],{"trials":1239,"activeCount":78},[],{"trials":1241,"activeCount":78},[],{"trials":1243,"activeCount":78},[1244],{"nctId":920,"briefTitle":921,"status":256,"phases":1245,"primaryCompletion":814,"completion":923,"start":924,"enrollment":925,"conditions":1246,"interventions":1247},[71],[914,927,915,18],[892,929,930,931],{"intervention":1249,"totalTrials":74,"cells":1250},"cholecalciferol",{"EARLY_PHASE1":1251,"PHASE1":1253,"PHASE2":1255,"PHASE3":1257,"PHASE4":1259,"NA":1261},{"trials":1252,"activeCount":78},[],{"trials":1254,"activeCount":78},[],{"trials":1256,"activeCount":78},[],{"trials":1258,"activeCount":78},[],{"trials":1260,"activeCount":78},[],{"trials":1262,"activeCount":78},[1263],{"nctId":1264,"briefTitle":1265,"status":256,"phases":1266,"primaryCompletion":1267,"completion":1267,"start":1019,"enrollment":756,"conditions":1268,"interventions":1272},"NCT00893451","Study of Vitamin D3 Supplementation in Patients With Chronic Kidney Disease",[71],"2011-06",[1269,1270,1271],"Chronic Kidney Disease","Insulin Resistance","Vitamin D Deficiency",[1249],{"intervention":1274,"totalTrials":74,"cells":1275},"Ursodeoxycholic Acid",{"EARLY_PHASE1":1276,"PHASE1":1278,"PHASE2":1280,"PHASE3":1282,"PHASE4":1284,"NA":1286},{"trials":1277,"activeCount":78},[],{"trials":1279,"activeCount":78},[],{"trials":1281,"activeCount":78},[],{"trials":1283,"activeCount":78},[],{"trials":1285,"activeCount":78},[],{"trials":1287,"activeCount":78},[1288],{"nctId":1289,"briefTitle":1290,"status":256,"phases":1291,"primaryCompletion":1292,"completion":1293,"start":1294,"enrollment":465,"conditions":1295,"interventions":1298},"NCT01548079","Ursodeoxycholic Acid in Bariatric Surgery",[71],"2009-11","2010-05","2008-10",[1296,1297],"Non-alcoholic Fatty Liver Disease","Morbid Obesity",[1274],{"intervention":769,"totalTrials":74,"cells":1300},{"EARLY_PHASE1":1301,"PHASE1":1303,"PHASE2":1305,"PHASE3":1307,"PHASE4":1309,"NA":1311},{"trials":1302,"activeCount":78},[],{"trials":1304,"activeCount":78},[],{"trials":1306,"activeCount":78},[],{"trials":1308,"activeCount":78},[],{"trials":1310,"activeCount":78},[],{"trials":1312,"activeCount":78},[1313],{"nctId":761,"briefTitle":762,"status":256,"phases":1314,"primaryCompletion":764,"completion":764,"start":527,"enrollment":765,"conditions":1315,"interventions":1316},[71],[410,767],[724,769],{"intervention":1318,"totalTrials":74,"cells":1319},"Magtrace",{"EARLY_PHASE1":1320,"PHASE1":1322,"PHASE2":1324,"PHASE3":1326,"PHASE4":1328,"NA":1330},{"trials":1321,"activeCount":78},[],{"trials":1323,"activeCount":78},[],{"trials":1325,"activeCount":78},[],{"trials":1327,"activeCount":78},[],{"trials":1329,"activeCount":78},[],{"trials":1331,"activeCount":78},[1332],{"nctId":1333,"briefTitle":1334,"status":460,"phases":1335,"primaryCompletion":1336,"completion":284,"start":1337,"enrollment":1083,"conditions":1338,"interventions":1341},"NCT06273501","MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer",[71],"2024-12-01","2022-03-24",[1339,1340],"Vulvar Cancer","Lymph Node Metastasis",[1318],{"intervention":1343,"totalTrials":74,"cells":1344},"Oxymetazoline, 0.05% Nasal Spray",{"EARLY_PHASE1":1345,"PHASE1":1347,"PHASE2":1349,"PHASE3":1351,"PHASE4":1353,"NA":1355},{"trials":1346,"activeCount":78},[],{"trials":1348,"activeCount":78},[],{"trials":1350,"activeCount":78},[],{"trials":1352,"activeCount":78},[],{"trials":1354,"activeCount":78},[],{"trials":1356,"activeCount":78},[1357],{"nctId":1358,"briefTitle":1359,"status":256,"phases":1360,"primaryCompletion":1361,"completion":1361,"start":1362,"enrollment":765,"conditions":1363,"interventions":1365},"NCT06480071","The Role of Nasal Breathing for Perfomance in Elite Athletes.",[71],"2022-03-17","2022-01-13",[1364],"Breathing, Mouth",[1343],{"intervention":1367,"totalTrials":74,"cells":1368},"Prednisolone",{"EARLY_PHASE1":1369,"PHASE1":1371,"PHASE2":1373,"PHASE3":1375,"PHASE4":1377,"NA":1379},{"trials":1370,"activeCount":78},[],{"trials":1372,"activeCount":78},[],{"trials":1374,"activeCount":78},[],{"trials":1376,"activeCount":78},[],{"trials":1378,"activeCount":78},[],{"trials":1380,"activeCount":78},[1381],{"nctId":1382,"briefTitle":1383,"status":256,"phases":1384,"primaryCompletion":1385,"completion":1385,"start":1386,"enrollment":115,"conditions":1387,"interventions":1389},"NCT04767711","Prevention of Glucocorticoid Induced Impairment of Bone Metabolism",[71],"2022-12-15","2022-05-16",[1388],"Bone Loss",[1367],{"intervention":1391,"totalTrials":74,"cells":1392},"H1N1 vaccine Pandemrix",{"EARLY_PHASE1":1393,"PHASE1":1395,"PHASE2":1397,"PHASE3":1399,"PHASE4":1401,"NA":1403},{"trials":1394,"activeCount":78},[],{"trials":1396,"activeCount":78},[],{"trials":1398,"activeCount":78},[],{"trials":1400,"activeCount":78},[],{"trials":1402,"activeCount":78},[],{"trials":1404,"activeCount":78},[1405],{"nctId":1406,"briefTitle":1407,"status":256,"phases":1408,"primaryCompletion":501,"completion":1409,"start":1410,"conditions":1411,"interventions":1413},"NCT01254955","Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients",[],"2011-08","2009-10",[1412],"Organ Transplantation",[1391],{"intervention":1415,"totalTrials":74,"cells":1416},"Sevorane Remifentanil",{"EARLY_PHASE1":1417,"PHASE1":1419,"PHASE2":1421,"PHASE3":1423,"PHASE4":1425,"NA":1427},{"trials":1418,"activeCount":78},[],{"trials":1420,"activeCount":78},[],{"trials":1422,"activeCount":78},[],{"trials":1424,"activeCount":78},[],{"trials":1426,"activeCount":78},[],{"trials":1428,"activeCount":78},[1429],{"nctId":1430,"briefTitle":1431,"status":256,"phases":1432,"primaryCompletion":1433,"completion":1433,"start":1434,"enrollment":1435,"conditions":1436,"interventions":1438},"NCT01872884","Sedation Versus General Anesthesia for Endovascular Therapy in Acute Stroke - Impact on Neurological Outcome",[71],"2016-09-30","2013-11-14",90,[1437],"Ischemic Stroke",[1415,1439],"Remifentanil",{"intervention":1439,"totalTrials":74,"cells":1441},{"EARLY_PHASE1":1442,"PHASE1":1444,"PHASE2":1446,"PHASE3":1448,"PHASE4":1450,"NA":1452},{"trials":1443,"activeCount":78},[],{"trials":1445,"activeCount":78},[],{"trials":1447,"activeCount":78},[],{"trials":1449,"activeCount":78},[],{"trials":1451,"activeCount":78},[],{"trials":1453,"activeCount":78},[1454],{"nctId":1430,"briefTitle":1431,"status":256,"phases":1455,"primaryCompletion":1433,"completion":1433,"start":1434,"enrollment":1435,"conditions":1456,"interventions":1457},[71],[1437],[1415,1439]]